90Y -positron emission tomography (PET) imaging is becoming a recognized modality for postinfusion quantitative assessment following radioembolization therapy. However, the extremely low counts and high random fraction associated with 90Y -PET may significantly impair both qualitative and quantitative results. The aim of this work was to study image quality and noise level in relation to the quantification and bias performance of two types of Siemens PET scanners when imaging 90Y and to compare experimental results with clinical data from two types of commercially available 90Y microspheres.
Data were acquired on both Siemens Biograph TruePoint [non-time-of-flight (TOF)] and Biograph microcomputed tomography (mCT) (TOF) PET/CT scanners. The study was conducted in three phases. The first aimed to assess quantification and bias for different reconstruction methods according to random fraction and number of true counts in the scan. The NEMA 1994 PET phantom was filled with water with one cylindrical insert left empty (air) and the other filled with a solution of 90Y . The phantom was scanned for 60 min in the PET/CT scanner every one or two days. The second phase used the NEMA 2001 PET phantom to derive noise and image quality metrics. The spheres and the background were filled with a 90Y solution in an 8:1 contrast ratio and four 30 min acquisitions were performed over a one week period. Finally, 32 patient data (8 treated with Therasphere® and 24 with SIR-Spheres®) were retrospectively reconstructed and activity in the whole field of view and the liver was compared to theoretical injected activity.
The contribution of both bremsstrahlung and LSO trues was found to be negligible, allowing data to be decay corrected to obtain correct quantification. In general, the recovered activity for all reconstruction methods was stable over the range studied, with a small bias appearing at extremely high random fraction and low counts for iterative algorithms. Point spread function (PSF) correction and TOF reconstruction in general reduce background variability and noise and increase recovered concentration. Results for patient data indicated a good correlation between the expected and PET reconstructed activities. A linear relationship between the expected and the measured activities in the organ of interest was observed for all reconstruction method used: a linearity coefficient of 0.89 ± 0.05 for the Biograph mCT and 0.81 ± 0.05 for the Biograph TruePoint.
Due to the low counts and high random fraction, accurate image quantification of 90Y during selective internal radionuclide therapy is affected by random coincidence estimation, scatter correction, and any positivity constraint of the algorithm. Nevertheless, phantom and patient studies showed that the impact of number of true and random coincidences on quantitative results was found to be limited as long as ordinary Poisson ordered subsets expectation maximization reconstruction algorithms with random smoothing are used. Adding PSF correction and TOF information to the reconstruction greatly improves the image quality in terms of bias, variability, noise reduction, and detectability. On the patient studies, the total activity in the field of view is in general accurately measured by Biograph mCT and slightly overestimated by the Biograph TruePoint.
- 1, , , , , , , and , “Intra-arterial treatment with 90Y microspheres for hepatocellular carcinoma: 4 years experience at Ghent University Hospital,” Eur. J. Nucl. Med. Mol. Imaging 38, 2117–2124 (2011).10.1007/s00259-011-1881-2
- 2 and , “Radioembolization with 90Yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies,” J. Vasc. Interv. Radiol. 17, 1251–1278 (2006).10.1097/01.RVI.0000233785.75257.9A
- 3, , and , “Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: Biological lessons, current challenges, and clinical perspectives,” Hepatology 58, 2188–2197 (2013).10.1002/hep.26382
- 4, , , , , , and , “Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres,” J. Nucl. Med. 52, 1930–1937 (2011).10.2967/jnumed.111.095232
- 5 et al., “Post-radioembolization yttrium-90 PET/CT - Part 2: Dose–Response and tumor predictive dosimetry for resin microspheres,” EJNMMI Res. 3, 57 (2013).10.1186/2191-219X-3-57
- 6, , , , , , and , “3D inpatient dose reconstruction from the PET-CT imaging of 90Y microspheres for metastatic cancer to the liver: Feasibility study,” Med. Phys. 40, 081702 (10pp.) (2013).10.1118/1.4810939
- 7, , , , , , and , “MIRD Pamphlet No. 23: Quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy,” J. Nucl. Med. 53, 1310–1325 (2012).10.2967/jnumed.111.100123
- 8 et al., “Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: Comparison between dose kernel convolution and direct Monte Carlo methods,” J. Nucl. Med. 54, 236–243 (2013).10.2967/jnumed.112.105825
- 9 and , “A collimator optimization method for quantitative imaging: Application to Y-90 bremsstrahlung SPECT,” Med. Phys. 40, 082504 (9pp.) (2013).10.1118/1.4813297
- 10, , , , and , “Quantitative Monte Carlo-based 90Y SPECT reconstruction,” J. Nucl. Med. 54, 1557–1563 (2013).10.2967/jnumed.112.119131
- 11, , , , , , and , “Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres,” Eur. J. Nucl. Med. Mol. Imaging 37, 1654–1662 (2010).10.1007/s00259-010-1470-9
- 12, , , , and , “Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: Proof of concept,” J. Nucl. Med. 52, 72–76 (2011).10.2967/jnumed.110.080986
- 13, , , and , “Treatment modification of yttrium-90 radioembolization based on quantitative positron emission tomography/CT imaging,” J. Vasc. Interv. Radiol. 24, 333–337 (2013).10.1016/j.jvir.2012.12.005
- 14, , , , , and , “4-step renal dosimetry dependant on cortex geometry applied to 90Y peptide receptor radiotherapy: Evaluation using a fillable kidney phantom imaged by 90Y PET,” J. Nucl. Med. 51, 1969–1973 (2010).10.2967/jnumed.110.080093
- 15 et al., “Quantitative evaluation on [90Y] DOTATOC PET and SPECT imaging by phantom acquisitions and clinical applications in locoregional and systemic treatments,” Q. J. Nucl. Med. Mol. Imaging 56, 522–528 (2012).
- 16, , , , and , “Quantitative 90Y image reconstruction in PET,” Med. Phys. 39, 7153–7159 (2012).10.1118/1.4762403
- 17, , , , , , , , , and , “Assessment of acquisition protocols for routine imaging of Y-90 using PET/CT,” EJNMMI Res. 3, 11 (2013).10.1186/2191-219X-3-11
- 18, , , , , and , “Study-parameter impact in quantitative 90-Yttrium PET imaging for radioembolization treatment monitoring and dosimetry,” IEEE Trans. Med. Imaging 32, 485–492 (2013).10.1109/TMI.2012.2221135
- 19, , , , , and , “The impact of image reconstruction bias on PET/CT 90Y dosimetry after radioembolization,” J. Nucl. Med. 55, 1452–1458 (2014).10.2967/jnumed.113.133629
- 20, , , , , , , , , and , “PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization,” Med. Phys. 41, 092503(10pp.) (2014).10.1118/1.4892383
- 21, , , , and , “Comparison of yttrium-90 quantitative imaging by TOF and non-TOF PET in a phantom of liver selective internal radiotherapy,” Phys. Med. Biol. 56, 6759–6777 (2011).10.1088/0031-9155/56/21/001
- 22, , , and , “Lifetime of the first excited state in 96 Zr*,” Phys. Lett. B 40, 357–359 (1972).10.1016/0370-2693(72)90819-2
- 23, , , , , , and , “Physics performance and clinical investigation of the mCT time-of-flight PET/CT scanner,” Phys. Med. Biol. 56, 2375–2389 (2011).10.1088/0031-9155/56/8/004
- 24, , , , , and , “Performance measurement of PSF modeling reconstruction (True X) on Siemens Biograph TruePoint TrueV PET/CT,” Ann. Nucl. Med. 28, 340–348 (2014).10.1007/s12149-014-0815-z
- 25, “Iterative algorithms for variance reduction on compressed sinogram random coincidences in PET,” in IEEE Nuclear Science Symposium Conference Record (IEEE, Dresden, Germany, 2008), pp. 3719–3725.
- 26, “New, faster, image-based scatter correction for 3D PET,” IEEE Trans. Nucl. Sci. 47, 1587–1594 (2000).10.1109/23.873020
- 27, , , and , “Advances in scatter correction for 3D PET/CT,” in IEEE Nuclear Science Symposium Conference Record (IEEE, Rome, Italy, 2004), Vol. 5, pp. 3008–3012.10.1109/NSSMIC.2004.1466317
- 28 and , “Estimation of the minimum detectable activity of preclinical PET imaging systems with an analytical method,” Med. Phys. 37, 6070–6083 (2010).10.1118/1.3495817
- 29, , and , “Noise and signal properties in PSF-based fully 3D PET image reconstruction: An experimental evaluation,” Phys. Med. Biol. 55, 1453–1473 (2010).10.1088/0031-9155/55/5/013
- 30, “Why is TOF PET reconstruction a more robust method in the presence of inconsistent data?,” Phys. Med. Biol. 56, 155–168 (2011).10.1088/0031-9155/56/1/010
- 31, “Effect of randoms on signal-to-noise-ratio in TOF PET,” IEEE Trans. Nucl. Sci. 53, 1188–1193 (2006).10.1109/TNS.2006.875066
- 32 and , “Randoms and TOF gain revisited,” Phys. Med. Biol. 60, 1613–1623 (2015).10.1088/0031-9155/60/4/1613